AMR

GHealth News - WHO has published its first global research agenda for the world’s scientists to address the most urgent human health priorities to combat antimicrobial resistance (AMR). It outlines 40 research topics on drug-resistant bacteria, fungi and Mycobacterium tuberculosis that must be answered by 2030, in line with the Sustainable Development Goals. The WHO Global Research Agenda for AMR in human health will catalyze innovation and implementation research, spanning the epidemiology, burden and drivers of AMR, context-specific and cost-effective strategies to prevent infections and emergence of resistance. It will also involve the discovery of new diagnostic tests and improved treatment regimens, the identification of cost-effective methods to collect data and translate it in...

The World Health Organization (WHO) is warning of a "silent pandemic" of antimicrobial resistance from infections caused by deadly pathogens that doctors are not able to cure because of a lack of novel agents.  That’s according to an early release of special presentations by Dr. Valeria Gigante and Professor Venkatasubramanian Ramasubramanian of an online "pre-meeting" of the European Congress of Clinical Microbiology & Infectious Diseases on April 15 to 18 in Copenhagen, Denmark. "Antibiotic resistance is one of the major concerns in modern medicine today," Dr. Aaron Glatt, chief of infectious diseases at Mount Sinai South Nassau Hospital on Long Island, New York, told Fox News Digital. EUROPEAN DRUG REGULATOR DETERMINES ANTIBIOTIC SHORTAGE NOT A ‘MAJOR EVENT’ ...

Andrew Jack and Chris Campbell Overuse of antibiotics by humans and in the farming of meat and fish is driving increased microbial resistance and threatening the availability of life-saving treatments. The World Health Organization calls antibiotic resistance one of the top 10 public health threats and the UN predicts up to 10m deaths a year from drug-resistant infections by 2050. Yet until recently there has been only a limited effort to measure trends in antibiotic use, their effects and to hold countries and companies to account. Governments, non-profits and investors alike are now starting to collect information to identify good and bad practices. Drug-resistant infections are a bigger problem in lower income countries The Centre for Disease Dynamics, Economics...